Textron Aviation's fourth-quarter 2024 profit sunk by nearly one-half year on year, due largely to a machinists' strike that ...
2021 Cessna Caravan 208 with only 580TT and Capital Executive Interior. Equipped with Garmin NXi Avionics Suite, GFC700 Autopilot, Synthetic Vision, TCAS, XM Weather & Radio, TAWS-B, Radar, TKS, ...
That's what GMC has done with the 2016 Sierra, the new Sierra Denali Ultimate adding even more content and showing off the truck's refreshed face and new Denali grille. The reasoning behind this ...
You can read Aircraft For Sale: Today’s Top Pick at FLYINGMag.com daily. Today’s Top Pick is a 1978 Cessna T210M Centurion. Piston pilots who regularly plan long cross-country flights and need ...
The research kicked off in November 2024, when NASA and a company called Reliable Robotics remotely flew a Cessna 208 Caravan over the settlement of Hollister, California. Back then, the specially ...
For the new report, the agency tested three unnamed prototypes with a maximum take off weight of below 6,500 lb (2,950 kg) in various rotor configurations and blade numbers.
The legendary manufacturer of ubiquitous general aviation models Cessna, has decades of experience developing reliable and efficient ... Another highly valuable metric for fleets that operate planes ...
Misses from amyotrophic lateral sclerosis hopefuls Denali Therapeutics and partners AbbVie and Calico Life Sciences mark the latest setbacks for the controversial platform trial, the results from ...
On January 7th, 2025, Australian aerospace authorities confirmed that a tragic aircraft crash had taken place near Thomson Bay in Western Australia, which involved a seaplane-configured Cessna 208 ...
The long-promised transportation dream is on the verge of becoming a reality, with big corporations investing hundreds of millions of dollars in their development. Spectators at a demonstration of ...
Tenvie Therapeutics has unveiled with $200 million and the goal of transforming the neurological treatment landscape, nabbing several programs—and an executive—from Denali Therapeutics.
A new company is making hay from an R&D shift at Denali Therapeutics, acquiring several of its neuroscience drug candidates and raising money from one of its original investors. The biotech ...